Investigational Site Number: 8400007

Kansas City, Missouri 64132

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, Plasma Cell Myeloma

Studies at this site

• A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant — Running, not enrolling
• Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older — Stopped early